Targeting the checkpoint kinase WEE1: Selective sensitization of cancer cells to DNA-damaging drugs: Cancer Biology & Therapy: Vol 9, No 7

388

Views

CrossRef citations to date

Altmetric

Abstract

Commentary to:

MK-1775, a small molecule Wee1 inhibitor, enhances anti-tumor efficacy of various DNA-damaging agents, including 5-fluorouracil

Hiroshi Hirai, Tsuyoshi Arai, Megumu Okada, Toshihide Nishibata, Makiko Kobayashi, Naoko Sakai, Kazuhide Imagaki, Junko Ohtani, Takumi Sakai, Takashi Yoshizumi, Shinji Mizuarai, Yoshikazu Iwasawa and Hidehito Kotani

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Targeting the checkpoint kinase WEE1: Selective sensitization of cancer cells to DNA-damaging drugs

Information for

Open access

Opportunities

Help and information

Targeting the checkpoint kinase WEE1: Selective sensitization of cancer cells to DNA-damaging drugs

Abstract

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature